Leerink Partners analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $42.00 (from $40.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Hot Comments

Hims and Hers (HIMS) PT Raised to $28 at BofA SecuritiesMay 6, 2025 6:59 AM Needham on Hims and Hers (HIMS): '2Q Transition Should Not Distract From HIMS Long-Term Trajectory'May 6, 2025 6:16 AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS)May 6, 2025 4:58 AM Leerink Partners Reiterates Market Perform Rating on Hims and Hers (HIMS)May 6, 2025 4:57 AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)May 6, 2025 4:57 AM Morgan Stanley on Hims and Hers (HIMS): 'This marked the first time in the company’s history that next quarter revenue was guided below the Street'May 6, 2025 4:51 AM Form 10-Q Hims & Hers Health, Inc. For: Mar 31May 5, 2025 4:18 PM Form 8-K Hims & Hers Health, Inc. For: May 05May 5, 2025 4:11 PM Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 3c; Issues Mixed OutlookMay 5, 2025 4:11 PM Hims & Hers Health, Inc. Reports First Quarter 2025 Financial ResultsMay 5, 2025 4:05 PM